enzalutamide
The following drugs will decrease enzalutamide effect
# | enzyme | inducers |
0 | 2C8 | rifampin |
1 | 3A457 | barbiturates |
2 | 3A457 | brigatinib |
3 | 3A457 | carbamazepine |
4 | 3A457 | clobazam |
5 | 3A457 | dabrafenib |
6 | 3A457 | efavirenz |
7 | 3A457 | elagolix |
8 | 3A457 | enzalutamide |
9 | 3A457 | eslicarbazepine |
10 | 3A457 | glucocorticoids |
11 | 3A457 | letermovir |
12 | 3A457 | lorlatinib |
13 | 3A457 | modafinil |
14 | 3A457 | nevirapine |
15 | 3A457 | oxcarbazepine |
16 | 3A457 | perampanel |
17 | 3A457 | phenobarbital |
18 | 3A457 | phenytoin |
19 | 3A457 | pioglitazone |
20 | 3A457 | rifabutin |
21 | 3A457 | rifampin |
22 | 3A457 | St. John's Wort |
23 | 3A457 | telotristat |
24 | 3A457 | troglitazone |
25 | 3A457 | vemurafenib |
the follwing drugs will
Increase enzalutamide effect
# | enzyme | Inhibitors | level |
0 | 2C8 | abiraterone | Weak inhibitor |
1 | 3A457 | amiodarone | under review |
2 | 3A457 | aprepitant | Moderate inhibitor |
3 | 3A457 | atomoxetine | |
4 | 3A457 | boceprevir | under review |
5 | 3A457 | ceritinib | Strong inhibitor |
6 | 3A457 | chloramphenicol | In-Vitro Only |
7 | 3A457 | cimetidine | |
8 | 3A457 | ciprofloxacin | under review |
9 | 3A457 | clarithromycin | Strong inhibitor |
10 | 2C8 | clopidogrel | Moderate inhibitor |
11 | 3A457 | crizotinib | Moderate inhibitor |
12 | 2C8 | deferasirox | Moderate inhibitor |
13 | 3A457 | delaviridine | under review |
14 | 3A457 | diethyl-dithiocarbamate | |
15 | 3A457 | diltiazem | Moderate inhibitor |
16 | 3A457 | entrectinib | |
17 | 3A457 | erythromycin | Moderate inhibitor |
18 | 3A457 | esomeprazole | |
19 | 3A457 | fluconazole | Moderate inhibitor |
20 | 3A457 | fluvoxamine | under review |
21 | 2C8 | gemfibrozil | Strong inhibitor |
22 | 3A457 | gestodene | under review |
23 | 2C8 | glitazones | In-Vitro Only |
24 | 3A457 | grapefruit juice | Moderate inhibitor |
25 | 3A457 | idelalisib | Strong inhibitor |
26 | 3A457 | imatinib | under review |
27 | 3A457 | indinavir | Strong inhibitor |
28 | 3A457 | itraconazole | Strong inhibitor |
29 | 3A457 | ivacaftor | |
30 | 3A457 | ketoconazole | Strong inhibitor |
31 | 2C8 | lapatinib | Weak inhibitor |
32 | 3A457 | lesinurad | |
33 | 2C8 | letermovir | In-Vitro Only |
34 | 3A457 | letermovir | |
35 | 3A457 | mibefradil | Strong inhibitor |
36 | 3A457 | mifepristone | under review |
37 | 2C8 | montelukast | In-Vitro Only |
38 | 3A457 | nefazodone | Strong inhibitor |
39 | 3A457 | nelfinavir | Strong inhibitor |
40 | 3A457 | netupitant/palonosetron | Moderate inhibitor |
41 | 3A457 | norfloxacin | under review |
42 | 3A457 | norfluoxetine | under review |
43 | 3A457 | omeprazole | Weak inhibitor |
44 | 3A457 | pantoprazole | |
45 | 2C8 | perampanel | In-Vitro Only |
46 | 3A457 | perampanel | |
47 | 2C8 | quercetin | In-Vitro Only |
48 | 3A457 | quercetin | |
49 | 3A457 | regorafenib | under review |
50 | 3A457 | ribociclib | Strong inhibitor |
51 | 3A457 | ritonavir | Strong inhibitor |
52 | 3A457 | rucaparib | |
53 | 3A457 | saquinavir | Strong inhibitor |
54 | 3A457 | simeprevir | |
55 | 3A457 | starfruit | under review |
56 | 3A457 | telaprevir | under review |
57 | 3A457 | telithromycin | Strong inhibitor |
58 | 2C8 | teriflunomide | Moderate inhibitor |
59 | 3A457 | ticagrelor | |
60 | 2C8 | trimethoprim | Moderate inhibitor |
61 | 2C8 | tucatinib | Weak inhibitor |
62 | 3A457 | tucatinib | Strong inhibitor |
63 | 3A457 | verapamil | Moderate inhibitor |
64 | 3A457 | voriconazole | Strong inhibitor |
The following drugs will decreased effect by enzalutamide effect
# | enzyme | drug |
1 | 3A457 | abemaciclib |
2 | 3A457 | abiraterone |
3 | 3A457 | acalabrutinib |
4 | 3A457 | alectinib |
5 | 3A457 | alfentanil |
6 | 3A457 | alprazolam |
7 | 2C19 | amitriptyline |
8 | 2C9 | amitriptyline |
9 | 3A457 | amitriptyline |
10 | 3A457 | amlodipine |
11 | 3A457 | apixaban |
12 | 3A457 | aprepitant |
13 | 3A457 | aripiprazole |
14 | 3A457 | astemizole |
15 | 2C19 | atomoxetine |
16 | 3A457 | atorvastatin |
17 | 3A457 | avanafil |
18 | 3A457 | axitinib |
19 | 2C9 | azilsartan |
20 | 3A457 | boceprevir |
21 | 3A457 | bosutinib |
22 | 3A457 | brexpiprazole |
23 | 3A457 | brigatinib |
24 | 2C19 | brivaracetam |
25 | 3A457 | buspirone |
26 | 3A457 | cafergot |
27 | 3A457 | caffeine |
28 | 2C9 | capecitabine |
29 | 3A457 | carbamazepine |
30 | 3A457 | cariprazine |
31 | 2C19 | carisoprodol |
32 | 2C19 | celecoxib |
33 | 2C9 | celecoxib |
34 | 3A457 | ceritinib |
35 | 3A457 | cerivastatin |
36 | 2C19 | chloramphenicol |
37 | 3A457 | chlorpheniramine |
38 | 3A457 | cilostazol |
39 | 3A457 | cisapride |
40 | 2C19 | citalopram |
41 | 3A457 | citalopram |
42 | 3A457 | clarithromycin |
43 | 2C19 | clobazam |
44 | 3A457 | clobazam |
45 | 2C19 | clomipramine |
46 | 2C19 | clopidogrel |
47 | 2C9 | clopidogrel |
48 | 3A457 | clopidogrel |
49 | 3A457 | cobimetinib |
50 | 3A457 | cocaine |
51 | 3A457 | codeine |
52 | 3A457 | colchicine |
53 | 3A457 | copanlisib |
54 | 3A457 | crizotinib |
55 | 2C19 | cyclophosphamide |
56 | 3A457 | cyclosporine |
57 | 3A457 | dabrafenib |
58 | 3A457 | daclatasvir |
59 | 3A457 | dapsone |
60 | 3A457 | deflazacort |
61 | 3A457 | dexamethasone |
62 | 3A457 | dextromethorphan |
63 | 2C19 | diazepam |
64 | 3A457 | diazepam |
65 | 2C9 | diclofenac |
66 | 3A457 | diltiazem |
67 | 3A457 | docetaxel |
68 | 3A457 | dolutegravir |
69 | 3A457 | domperidone |
70 | 2C19 | doxepin |
71 | 2C9 | doxepin |
72 | 3A457 | doxepin |
73 | 3A457 | elagolix |
74 | 3A457 | elbasvir/grazoprevir |
75 | 3A457 | eliglustat |
76 | 3A457 | enzalutamide |
77 | 3A457 | eplerenone |
78 | 3A457 | erythromycin2 |
79 | 2C19 | escitalopram |
80 | 3A457 | escitalopram |
81 | 2C19 | esomeprazole |
82 | 3A457 | esomeprazole |
83 | 3A457 | estradiol |
84 | 3A457 | felodipine |
85 | 3A457 | fentanyl |
86 | 3A457 | finasteride |
87 | 2C19 | flibanserin |
88 | 3A457 | flibanserin |
89 | 2C9 | fluoxetine |
90 | 2C9 | fluvastatin |
91 | 3A457 | gleevec |
92 | 2C9 | glibenclamide |
93 | 2C9 | glimepiride |
94 | 2C9 | glipizide |
95 | 2C9 | glyburide |
96 | 3A457 | haloperidol |
97 | 2C19 | hexobarbital |
98 | 3A457 | hydrocortisone |
99 | 3A457 | ibrutinib |
100 | 2C9 | ibuprofen |
101 | 3A457 | idelalisib |
102 | 2C19 | imipramine |
103 | 3A457 | indacaterol |
104 | 3A457 | indinavir |
105 | 2C19 | indomethacin |
106 | 2C9 | irbesartan |
107 | 3A457 | irinotecan |
108 | 3A457 | isavuconazonium |
109 | 3A457 | ivabradine |
110 | 3A457 | ivacaftor |
111 | 3A457 | LAAM |
112 | 2C19 | labetalol |
113 | 2C19 | lansoprazole |
114 | 3A457 | lansoprazole |
115 | 3A457 | lenvatinib |
116 | 3A457 | lercanidipine |
117 | 2C9 | lesinurad |
118 | 3A457 | lidocaine |
119 | 3A457 | linagliptin |
120 | 2C9 | lornoxicam |
121 | 2C9 | losartan |
122 | 3A457 | lovastatin |
123 | 3A457 | macitentan |
124 | 2C19 | mavacamten |
125 | 3A457 | mavacamten |
126 | 2C9 | meloxicam |
127 | 3A457 | methadone |
128 | 3A457 | midazolam |
129 | 2C19 | moclobemide |
130 | 3A457 | naldemedine |
131 | 3A457 | naloxegol |
132 | 2C9 | nateglinide |
133 | 3A457 | nateglinide |
134 | 2C19 | nelfinavir |
135 | 3A457 | nelfinavir |
136 | 3A457 | neratinib |
137 | 3A457 | netupitant/palonosetron |
138 | 3A457 | nevirapine |
139 | 3A457 | nifedipine |
140 | 2C19 | nilutamide |
141 | 3A457 | nirmatrelvir |
142 | 3A457 | nisoldipine |
143 | 3A457 | nitrendipine |
144 | 3A457 | olaparib |
145 | 2C9 | olodaterol |
146 | 2C19 | omeprazole |
147 | 3A457 | omeprazole |
148 | 3A457 | ondansetron |
149 | 3A457 | osimertinib |
150 | 2C19 | ospemifene |
151 | 2C9 | ospemifene |
152 | 3A457 | ospemifene |
153 | 3A457 | palbociclib |
154 | 3A457 | panobinostat |
155 | 2C19 | pantoprazole |
156 | 3A457 | pantoprazole |
157 | 3A457 | perampanel |
158 | 2C19 | phenobarbitone |
159 | 2C19 | phenytoin |
160 | 2C9 | phenytoin |
161 | 3A457 | pimavanserin |
162 | 3A457 | pimozide |
163 | 2C9 | piroxicam |
164 | 2C19 | pomalidomide |
165 | 3A457 | pomalidomide |
166 | 3A457 | ponatinib |
167 | 2C19 | primidone |
168 | 2C19 | progesterone |
169 | 3A457 | progesterone |
170 | 2C19 | proguanil |
171 | 2C19 | propranolol |
172 | 3A457 | propranolol |
173 | 3A457 | quetiapine |
174 | 3A457 | quinidine |
175 | 3A457 | quinine |
176 | 2C19 | r-mephobarbital |
177 | 2C19 | r-warfarin |
178 | 3A457 | regorafenib |
179 | 3A457 | ribociclib |
180 | 3A457 | rilpivirine |
181 | 3A457 | risperidone |
182 | 3A457 | ritonavir |
183 | 3A457 | rivaroxaban |
184 | 3A457 | roflumilast |
185 | 3A457 | rolapitant |
186 | 3A457 | romidepsin |
187 | 2C9 | rosiglitazone |
188 | 3A457 | rucaparib |
189 | 3A457 | ruxolitinib |
190 | 2C19 | s-mephenytoin |
191 | 2C9 | s-warfarin |
192 | 3A457 | salmeterol |
193 | 3A457 | saquinavir |
194 | 3A457 | selexipag |
195 | 3A457 | sildenafil |
196 | 3A457 | simeprevir |
197 | 3A457 | simvastatin |
198 | 3A457 | sirolimus |
199 | 3A457 | sonidegib |
200 | 3A457 | sorafenib |
201 | 3A457 | sunitinib |
202 | 2C9 | suprofen |
203 | 2C19 | suvorexant |
204 | 3A457 | suvorexant |
205 | 3A457 | tacrolimus(fk506) |
206 | 2C9 | tamoxifen |
207 | 3A457 | tamoxifen |
208 | 3A457 | tasimelteon |
209 | 3A457 | taxol |
210 | 3A457 | telaprevir |
211 | 3A457 | telithromycin |
212 | 2C19 | teniposide |
213 | 3A457 | terfenadine |
214 | 3A457 | testosterone |
215 | 3A457 | ticagrelor |
216 | 2C19 | tofacitinib |
217 | 3A457 | tofacitinib |
218 | 2C9 | tolbutamide |
219 | 3A457 | tolvaptan |
220 | 3A457 | torisel |
221 | 2C9 | torsemide |
222 | 3A457 | tramadol |
223 | 3A457 | trazodone |
224 | 3A457 | valbenazine |
225 | 2C9 | valproic acid |
226 | 3A457 | vandetanib |
227 | 3A457 | velpatasvir |
228 | 3A457 | vemurafenib |
229 | 3A457 | venetoclax |
230 | 2C19 | venlafaxine |
231 | 2C9 | venlafaxine |
232 | 3A457 | venlafaxine |
233 | 3A457 | verapamil |
234 | 2C19 | vilazodone |
235 | 3A457 | vilazodone |
236 | 3A457 | vincristine |
237 | 3A457 | vorapaxar |
238 | 2C19 | voriconazole |
239 | 2C9 | voriconazole |
240 | 3A457 | voriconazole |
241 | 2C9 | zafirlukast |
242 | 3A457 | zaleplon |
243 | 3A457 | ziprasidone |
244 | 3A457 | zolpidem |
will
decrease enzalutamide effect
enzalutamide will not affect
Strong inhibitor is one that causes a ≥ 5-fold decrease in the plasma AUC values or more than 80% decrease in clearance.
Moderate inhibitor is one that causes a 2 fold to < 5-fold decrease in the plasma AUC values or 50-80% decrease in clearance.
Weak inhibitor is one that causes a ≥ 1.25-fold but < 2-fold decrease in the plasma AUC values or 20-50% decrease in clearance.
In-Vitro Only In-Vitro Only Inhibitor strength.
under review Inhibitor strength level is under review.